Gemmer Asset Management LLC Sorrento Therapeutics, Inc. Transaction History

Gemmer Asset Management LLC

  • $969 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022
SELL
$1.24 - $2.33 $1,282 - $2,409
-1,034 Closed
0 $0
Q2 2021

Jul 23, 2021
SELL
$6.35 - $10.0 $317 - $500
-50 Reduced 4.61%
1,034 $10,000
Q1 2021

Apr 20, 2021
BUY
$7.03 - $16.51 $6,917 - $16,245
984 Added 984.0%
1,084 $9,000
Q2 2020

Jul 31, 2020
BUY
$1.73 - $6.76 $173 - $676
100 New
100 $1,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Gemmer Asset Management LLC Portfolio

Follow Gemmer Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gemmer Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email